Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

222986

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal System
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that patients have timely and direct access to (a) gastroenterologists and (b) other specialist clinicians.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224974
answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>Health Education England (HEE) is responsible for workforce planning and education commissioning activity to ensure that the National Health Service in England has available a future workforce in the right numbers, with the right skills, values and behaviours.</p><p> </p><p> </p><p> </p><p>In December 2014, HEE published its second national Workforce Plan for England for the period 2015/16 which is built upon the needs of local employers, commissioners and other stakeholders. The priorities in the plan are the priorities of the NHS, identified locally and nationally by employers, professional bodies and other stakeholders.</p><p> </p><p> </p><p> </p><p>National recruitment into gastroenterology training posts in 2013 and 2014 achieved 100% fill-rate. There have been no reductions in the planned commissions of gastroenterologists for 2015/16.</p><p> </p><p> </p><p> </p><p>The following table shows the number of full-time equivalent doctors and gastroenterologists, excluding locums, working in hospital and community health services in England.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Full-Time Equivalent</p></td><td><p>May 2010</p></td><td><p>November 2014</p></td><td colspan="2"><p>Change May 2010 to November 2014</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>All Doctors</p></td><td><p>95,421</p></td><td><p>105,001</p></td><td><p>9,580</p></td><td><p>10.0%</p></td></tr><tr><td><p><em>of which, with specialty of:</em></p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Gastroenterology</p></td><td><p>1,788</p></td><td><p>2,309</p></td><td><p>521</p></td><td><p>29.1%</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Health and Social Care Information Centre, Monthly Workforce Statistics, Nov 2014</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 224978 question first answered 26/02/2015 11:35:36 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1538 label Biography information for Rosie Cooper

222992

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal System
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that there are sufficient (a) specialist clinician trainees and (b) gastroenterologist trainees in the health education and training system.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224978
answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>Health Education England (HEE) is responsible for workforce planning and education commissioning activity to ensure that the National Health Service in England has available a future workforce in the right numbers, with the right skills, values and behaviours.</p><p> </p><p> </p><p> </p><p>In December 2014, HEE published its second national Workforce Plan for England for the period 2015/16 which is built upon the needs of local employers, commissioners and other stakeholders. The priorities in the plan are the priorities of the NHS, identified locally and nationally by employers, professional bodies and other stakeholders.</p><p> </p><p> </p><p> </p><p>National recruitment into gastroenterology training posts in 2013 and 2014 achieved 100% fill-rate. There have been no reductions in the planned commissions of gastroenterologists for 2015/16.</p><p> </p><p> </p><p> </p><p>The following table shows the number of full-time equivalent doctors and gastroenterologists, excluding locums, working in hospital and community health services in England.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Full-Time Equivalent</p></td><td><p>May 2010</p></td><td><p>November 2014</p></td><td colspan="2"><p>Change May 2010 to November 2014</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>All Doctors</p></td><td><p>95,421</p></td><td><p>105,001</p></td><td><p>9,580</p></td><td><p>10.0%</p></td></tr><tr><td><p><em>of which, with specialty of:</em></p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Gastroenterology</p></td><td><p>1,788</p></td><td><p>2,309</p></td><td><p>521</p></td><td><p>29.1%</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Health and Social Care Information Centre, Monthly Workforce Statistics, Nov 2014</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 224974 question first answered 26/02/2015 11:35:36 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1538 label Biography information for Rosie Cooper

222580

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psoriasis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 9 April 2014, Official Report, columns 261-3W, on psoriasis, what the conclusions were of the NICE Clinical Commissioning Group Outcomes Indicator Set Advisory Committee's review of potential indicators for psoriasis derived from the NICE Psoriasis Quality Standard.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224746
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) Clinical Commissioning Group Outcome Indicator Set (CCG OIS) Advisory Committee considered the following draft psoriasis indicators, derived from the NICE Psoriasis Quality Standard, at its meeting in October 2014:</p><p> </p><p> </p><p> </p><p>- PSO 5.1 Psoriasis: assessment for psoriatic arthritis;</p><p> </p><p>- PSO 6.2 Skin disease: time off school or work due to skin disease;</p><p> </p><p>- PSO 6.3 Psoriasis: skin clearance; and</p><p> </p><p>- PSO 3.2 Psoriasis: Patient experience: access to secondary care services.</p><p> </p><p> </p><p> </p><p>It was the decision of the committee that the indicators did not meet the prioritisation criteria, as set out in the NICE Indicator Process guide. The primary reason for this was that the majority of care for people with psoriasis is provided in primary care and the CCG OIS is focused on care provided in secondary care. As such, the committee has not put forward any of the psoriasis indicators for further development and testing by the Health and Social Care Information Centre (HSCIC). The HSCIC has not, therefore, undertaken any further work on the development of Read Codes for this topic.</p><p> </p><p> </p><p> </p><p>The NICE indicator process guide and the NICE consultation document setting out those indicators which did meet the prioritisation criteria can be found at the links below:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf" target="_blank">www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf</a></p><p> </p><p><a href="http://www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf" target="_blank">www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf</a></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 224748 224749 question first answered 25/02/2015 14:56:14 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

222581

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 1 December 2014 to Question 216131, what processes will be used to promote specialised commissioning expenditure against nominal clinical commissioning groups budgets; and how the present central NHS England budget for commissioning dialysis services will be transferred to clinical commissioning groups.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224747
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Significant work has been undertaken by NHS England to analyse current specialised commissioning expenditure patterns at clinical commissioning group (CCG) level. This CCG level monitoring will continue in 2015/16 with the aim of improving commissioning decisions.</p><p> </p><p> </p><p> </p><p>There is no planned transfer of renal dialysis budgets from NHS England to CCGs in either the current financial year or during 2015-16. It is for Ministers to decide, with independent advice, the conditions that should be on the specialised commissioning list.</p><p> </p><p> </p><p> </p><p>Neither NHS England specialised commissioners nor CCGs have control over capital funding for dialysis facilities and maintenance. Capital funding for renewal of dialysis facilities and equipment remains with the incumbent providers. Ensuring that these facilities are of appropriate quality is achieved through the application of detailed service specifications which form part of the contract with providers.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 224750 question first answered 25/02/2015 17:57:27 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

222582

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psoriasis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 9 April 2014, Official Report, columns 261-3W, on psoriasis, what indicators have been proposed to the NICE Clinical Commissioning Group Outcomes Indicator Set Advisory Committee for psoriasis.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224748
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) Clinical Commissioning Group Outcome Indicator Set (CCG OIS) Advisory Committee considered the following draft psoriasis indicators, derived from the NICE Psoriasis Quality Standard, at its meeting in October 2014:</p><p> </p><p> </p><p> </p><p>- PSO 5.1 Psoriasis: assessment for psoriatic arthritis;</p><p> </p><p>- PSO 6.2 Skin disease: time off school or work due to skin disease;</p><p> </p><p>- PSO 6.3 Psoriasis: skin clearance; and</p><p> </p><p>- PSO 3.2 Psoriasis: Patient experience: access to secondary care services.</p><p> </p><p> </p><p> </p><p>It was the decision of the committee that the indicators did not meet the prioritisation criteria, as set out in the NICE Indicator Process guide. The primary reason for this was that the majority of care for people with psoriasis is provided in primary care and the CCG OIS is focused on care provided in secondary care. As such, the committee has not put forward any of the psoriasis indicators for further development and testing by the Health and Social Care Information Centre (HSCIC). The HSCIC has not, therefore, undertaken any further work on the development of Read Codes for this topic.</p><p> </p><p> </p><p> </p><p>The NICE indicator process guide and the NICE consultation document setting out those indicators which did meet the prioritisation criteria can be found at the links below:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf" target="_blank">www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf</a></p><p> </p><p><a href="http://www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf" target="_blank">www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf</a></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 224746 224749 question first answered 25/02/2015 14:56:14 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

222583

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psoriasis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 9 April 2014, Official Report, columns 261-3W, on psoriasis, what development to Read codes was found to be necessary by the Health and Social Care Information Centre to support the indicators proposed for psoriasis.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224749
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) Clinical Commissioning Group Outcome Indicator Set (CCG OIS) Advisory Committee considered the following draft psoriasis indicators, derived from the NICE Psoriasis Quality Standard, at its meeting in October 2014:</p><p> </p><p> </p><p> </p><p>- PSO 5.1 Psoriasis: assessment for psoriatic arthritis;</p><p> </p><p>- PSO 6.2 Skin disease: time off school or work due to skin disease;</p><p> </p><p>- PSO 6.3 Psoriasis: skin clearance; and</p><p> </p><p>- PSO 3.2 Psoriasis: Patient experience: access to secondary care services.</p><p> </p><p> </p><p> </p><p>It was the decision of the committee that the indicators did not meet the prioritisation criteria, as set out in the NICE Indicator Process guide. The primary reason for this was that the majority of care for people with psoriasis is provided in primary care and the CCG OIS is focused on care provided in secondary care. As such, the committee has not put forward any of the psoriasis indicators for further development and testing by the Health and Social Care Information Centre (HSCIC). The HSCIC has not, therefore, undertaken any further work on the development of Read Codes for this topic.</p><p> </p><p> </p><p> </p><p>The NICE indicator process guide and the NICE consultation document setting out those indicators which did meet the prioritisation criteria can be found at the links below:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf" target="_blank">www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf</a></p><p> </p><p><a href="http://www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf" target="_blank">www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf</a></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 224746 224748 question first answered 25/02/2015 14:56:15 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

222584

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dialysis Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the transfer of kidney dialysis commissioning to local clinical commissioning groups on future capital funding for maintenance and renewal of dialysis facilities and equipment.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224750
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Significant work has been undertaken by NHS England to analyse current specialised commissioning expenditure patterns at clinical commissioning group (CCG) level. This CCG level monitoring will continue in 2015/16 with the aim of improving commissioning decisions.</p><p> </p><p> </p><p> </p><p>There is no planned transfer of renal dialysis budgets from NHS England to CCGs in either the current financial year or during 2015-16. It is for Ministers to decide, with independent advice, the conditions that should be on the specialised commissioning list.</p><p> </p><p> </p><p> </p><p>Neither NHS England specialised commissioners nor CCGs have control over capital funding for dialysis facilities and maintenance. Capital funding for renewal of dialysis facilities and equipment remains with the incumbent providers. Ensuring that these facilities are of appropriate quality is achieved through the application of detailed service specifications which form part of the contract with providers.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 224747 question first answered 25/02/2015 17:57:27 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

174578

registered interest
date	14/01/2015
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Middle East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent assessment he has made of the extent of persecution of Christian communities in the Middle East.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	907109
answer	answer is ministerial correction date of answer 20/01/2015 answer text <p>We are deeply concerned by the difficulties facing many Christians and religious minorities in the Middle East and deplore all discrimination and constraints on freedom of religion.</p><p>We are committed to supporting the fundamental human right to freedom of religion or belief. We support this right for Christian communities in the Middle East by regularly urging governments at senior levels to uphold the rights of all minorities; building international consensus on freedom of religion or belief; and supporting practical projects on community dialogue with civil society and faith groups.</p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood question first answered 20/01/2015 15:05:39 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	1538 label Biography information for Rosie Cooper

169973

registered interest
date	11/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Kidney Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients in England with advanced renal cell carcinoma have accessed treatment through the Cancer Drug Fund since April 2013.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	218434
answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>NHS England has advised that it does not hold this information centrally.</p><p> </p><p> </p><p> </p><p>Between April 2013 and 30 September 2014, there have been 1,227 requests for drugs for advanced renal cell carcinoma through the Cancer Drugs Fund. However, actual uptake of treatment is dependent on variables which are unique to the patient’s individual clinical circumstances, the progression of the disease and the patient’s own choices.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/12/2014 17:26:39 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

169995

registered interest
date	11/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Kidney Cancer: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the approval by the Scottish Medicines Consortium of two second line treatments for renal cell carcinoma, if he will direct the Cancer Drug Fund panel to ensure that patients in England will continue to have access to treatments that are available on the NHS in Scotland for that condition.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	218530
answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>We have no plans to do so. Decisions on which drugs are made available through the Cancer Drugs Fund are for NHS England’s Cancer Drugs Fund panel, in accordance with the Standard Operating Procedures for the Fund.</p><p> </p><p> </p><p> </p><p>There are two drugs for the second-line treatment of renal cell carcinoma – Afinitor (everolimus) and Inlyta (axitinib) - currently available through the Fund.</p><p> </p><p> </p><p> </p><p>Inlyta is also being appraised for this condition by the National Institute for Health and Care Excellence and final draft guidance recommending its use was published on 16 December 2014.</p><p> </p><p> </p><p> </p><p>NHS England has assured the Department that no patient whose treatment is currently being funded through the Cancer Drugs Fund will have funding withdrawn, as long as it is clinically appropriate that they continue to receive that treatment. In addition, no drug will be removed from the Fund where it is the only therapy for that condition.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/12/2014 17:23:20 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper